$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs

$pavs Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 20-F Financial Statement

#000192998024000320 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2024
Revenue		$250.9K	$6.545M
YoY Change		-99.44%	-93.33%
Cost Of Revenue		$247.0K	$6.536M
YoY Change		-99.42%	-92.98%
Gross Profit		$3.890K	$9.141K
YoY Change		-99.85%	-99.82%
Gross Profit Margin		1.55%	0.14%
Selling, General & Admin		-$7.906M	$2.823M
YoY Change		-118.59%	-95.6%
% of Gross Profit		-203236.5%	30882.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$354.5K	$1.126K
YoY Change		-81.05%	-99.93%
% of Gross Profit		9111.83%	12.32%
Operating Expenses		-$7.906M	-$4.631M
YoY Change		-118.17%	-106.3%
Operating Profit		$7.910M	-$4.622M
YoY Change		-119.29%	-93.24%
Interest Expense		-$40.04K	$39.17K
YoY Change		100.2%	-45.83%
% of Operating Profit		-0.51%
Other Income/Expense, Net		$3.874M	$831.5K
YoY Change			-348.08%
Pretax Income		-$13.54M	-$3.790M
YoY Change		-72.31%	-94.49%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings		-$18.32M	-$6.980M
YoY Change		-65.01%	-90.27%
Net Earnings / Revenue		-7303.95%	-106.64%
Basic Earnings Per Share
Diluted Earnings Per Share		-$3.87	-$2.13
COMMON SHARES
Basic Shares Outstanding	612.3K shares		4.733M shares
Diluted Shares Outstanding			4.733M shares

Balance Sheet

Concept	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$944.2K	$944.2K
YoY Change	-72.23%	-72.23%
Cash & Equivalents	$944.2K	$944.2K
Short-Term Investments
Other Short-Term Assets	$47.35K	$1.896M
YoY Change	-82.06%	-56.91%
Inventory
Prepaid Expenses
Receivables	$11.36K	$11.36K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.852M	$2.852M
YoY Change	-70.86%	-70.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.60K	$12.60K
YoY Change	-99.85%	-99.85%
Goodwill	$3.376M
YoY Change	-47.7%
Intangibles	$1.488M
YoY Change	-84.24%
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$4.877M	$4.877M
YoY Change	-81.63%	-81.6%
TOTAL ASSETS
Total Short-Term Assets	$2.852M	$2.852M
Total Long-Term Assets	$4.877M	$4.877M
Total Assets	$7.729M	$7.729M
YoY Change	-78.73%	-78.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.560M	$2.560M
YoY Change	-80.98%	-86.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.560M	$2.560M
YoY Change	-87.78%	-87.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.560M	$2.560M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$2.560M	$2.148M
YoY Change	-88.6%	-90.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.96M
YoY Change	4.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.581M	$5.581M
YoY Change
Total Liabilities & Shareholders Equity	$7.729M	$7.729M
YoY Change	-78.73%	-78.71%

Cashflow Statement

Concept	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$18.32M	-$6.980M
YoY Change	-65.01%	-90.27%
Depreciation, Depletion And Amortization	$354.5K	$1.126K
YoY Change	-81.05%	-99.93%
Cash From Operating Activities	-$169.6K	-$11.88M
YoY Change	-98.68%	-43.69%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$543.0K	$11.70M
YoY Change	352.53%	8255.99%
Cash From Investing Activities	$543.0K	$11.70M
YoY Change	239.4%	12996.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$0.00
YoY Change	-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-169.6K	-$11.88M
Cash From Investing Activities	543.0K	$11.70M
Cash From Financing Activities	0.000	$0.00
Net Change In Cash	373.4K	-$1.105M
YoY Change	-103.34%	-93.25%
FREE CASH FLOW
Cash From Operating Activities	-$169.6K	-$11.88M
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$169.6K	-$11.88M
YoY Change	-98.68%	-43.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001751876
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	612255	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	pavs	Preferred Shares Shares Outstanding PreferredSharesSharesOutstanding	0	shares
CY2024Q1	pavs	Preferred Shares Shares Outstanding PreferredSharesSharesOutstanding	0	shares
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.72
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.75
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-2.89
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.08
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-11.92
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40485912	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40485912	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4732726	shares
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	5894	usd
CY2024	pavs	Depreciation Expense DepreciationExpense	0	usd
CY2023	pavs	Depreciation Expense DepreciationExpense	0	usd
CY2024Q1	pavs	Aggregate Loan Amount AggregateLoanAmount	2250000.00	usd
CY2024Q1	pavs	Aggregate Loan Amount AggregateLoanAmount	2250000.00	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Granted Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantedPrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageForfeited	0
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	0	shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Exercised In Periods ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsExercisedInPeriods	0
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.1	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.1	pure
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	333-230170
CY2024	dei	Entity Registrant Name EntityRegistrantName	Paranovus Entertainment Technology Ltd.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	250 Park Avenue
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	7th Floor
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10177
CY2024	dei	Security12b Title Security12bTitle	Class A ordinary shares, par value US$0.01 per share
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	true
CY2024	dei	Auditor Firm AuditorFirmId	6706
CY2024	dei	Auditor Name AuditorName	TPS Thayer, LLC
CY2024	dei	Auditor Location AuditorLocation	Sugar Land, TX
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	944242	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2049362	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11360	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1896109	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3307502	usd
CY2024Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	4429107	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2851711	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9785971	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12596	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13470	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1488333	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1868333	usd
CY2024Q1	us-gaap	Goodwill Goodwill	3376186	usd
CY2023Q1	us-gaap	Goodwill Goodwill	5184036	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	252	usd
CY2024Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	19488147	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	4877115	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	26554238	usd
CY2024Q1	us-gaap	Assets Assets	7728826	usd
CY2023Q1	us-gaap	Assets Assets	36340209	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2560381	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	723310	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	8987	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	20220781	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2560381	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20953078	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1514060	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1514060	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2560381	usd
CY2023Q1	us-gaap	Liabilities Liabilities	22467138	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64918726	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66908726	usd
CY2024Q1	pavs	Statutory Surplus Reserve StatutorySurplusReserve	0	usd
CY2023Q1	pavs	Statutory Surplus Reserve StatutorySurplusReserve	7622765	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61957019	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59453593	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2545619	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-402119	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5580626	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14759079	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-412181	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-886008	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5168445	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13873071	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7728826	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36340209	usd
CY2024	us-gaap	Revenues Revenues	6544819	usd
CY2023	us-gaap	Revenues Revenues	23332223	usd
CY2022	us-gaap	Revenues Revenues	20758645	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	6535678	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	22915340	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	20501385	usd
CY2024	us-gaap	Gross Profit GrossProfit	9141	usd
CY2023	us-gaap	Gross Profit GrossProfit	416883	usd
CY2022	us-gaap	Gross Profit GrossProfit	257260	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38317	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1632828	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8862101	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2784628	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3333148	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2560191	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1807850	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	-4630795	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	-4965976	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	-11422292	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-4621654	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4549093	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11165032	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	345	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	316	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1539	usd
CY2024	us-gaap	Interest Expense InterestExpense	39167	usd
CY2023	us-gaap	Interest Expense InterestExpense	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	0	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	870303	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21728	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	964198	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	831481	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22044	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	965737	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3790173	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4527049	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10199295	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2996	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	696	usd
CY2024	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3790173	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4530045	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10199991	usd
CY2024	pavs	Net Loss From Discontinued Operations Before Tax NetLossFromDiscontinuedOperationsBeforeTax	-13780209	usd
CY2023	pavs	Net Loss From Discontinued Operations Before Tax NetLossFromDiscontinuedOperationsBeforeTax	-64202987	usd
CY2022	pavs	Net Loss From Discontinued Operations Before Tax NetLossFromDiscontinuedOperationsBeforeTax	-47547013	usd
CY2024	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	7547428	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-95630	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3454084	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3726923	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6137151	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-67657071	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-43820090	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-9927324	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54020081	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	198867	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-448242	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4829471	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10126191	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-71738874	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49190610	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	3222698	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4435667	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2523258	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6704626	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-76622783	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51496823	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-274960	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-272988	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2696899	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-6979586	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-76895771	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-48799924	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.75
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.72
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-2.89
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-11.92
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.08
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4732726	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5678081	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40485912	shares
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	97637056	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18877600	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1086231	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11310540	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2022	pavs	Net Income Loss During Period NetIncomeLossDuringPeriod	-54020081	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2523258	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77414604	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6000000	usd
CY2023	pavs	Stock Issued During Period For Share Sonsolidation Amount StockIssuedDuringPeriodForShareSonsolidationAmount	0	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7081250	usd
CY2023	pavs	Convention Of Class A Ordinary Shares Into Class B Ordinary Shares Amount ConventionOfClassAOrdinarySharesIntoClassBOrdinarySharesAmount	0	usd
CY2023	pavs	Net Income Loss During Period NetIncomeLossDuringPeriod	-72187116	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4435667	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13873071	usd
CY2024	pavs	Share Cancellation Amount ShareCancellationAmount	-2000000	usd
CY2024	pavs	Net Income Loss During Period NetIncomeLossDuringPeriod	3757255	usd
CY2024	pavs	Stock Issued During Period For Discontinued Operations Disposal StockIssuedDuringPeriodForDiscontinuedOperationsDisposal	-13684579	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3222698	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5168445	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-9927324	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54020081	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	381126	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58751	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34610	usd
CY2024	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1	1807850	usd
CY2023	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1	0	usd
CY2022	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1	0	usd
CY2024	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment	0	usd
CY2023	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment	-87122	usd
CY2022	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1086231	usd
CY2024	pavs	Gain On Disposal Of Discontinued Operations GainOnDisposalOfDiscontinuedOperations	7547428	usd
CY2023	pavs	Gain On Disposal Of Discontinued Operations GainOnDisposalOfDiscontinuedOperations	3039676	usd
CY2022	pavs	Gain On Disposal Of Discontinued Operations GainOnDisposalOfDiscontinuedOperations	0	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11360	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13516	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13516	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-344479	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	344479	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	588607	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1034655	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4342157	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-310859	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	311111	usd
CY2024	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-557791	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2180921	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2904231	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4712	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4275	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16443534	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-75553620	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-55001997	usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	4568288	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	72586577	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	44503488	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11875246	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2967042	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10498509	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	273650	usd
CY2024	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-11698379	usd
CY2023	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	usd
CY2022	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	11698379	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-273650	usd
CY2024	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	89322	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-8205471	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11698379	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	89322	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8479121	usd
CY2024	pavs	Ordinary Shares Issued For Cash OrdinarySharesIssuedForCash	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	18877600	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	0	usd
CY2023	pavs	Ordinary Shares Issued For Cash OrdinarySharesIssuedForCash	3000000	usd
CY2022	pavs	Ordinary Shares Issued For Cash OrdinarySharesIssuedForCash	18877600	usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	145524	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-46814	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3145524	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18830786	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-928253	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1477741	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95575	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1105120	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1745545	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-51269	usd
CY2024	pavs	Cash And Cash Equivalents Of Continuing Operations Beginning Of Year CashAndCashEquivalentsOfContinuingOperationsBeginningOfYear	2049362	usd
CY2023	pavs	Cash And Cash Equivalents Of Continuing Operations Beginning Of Year CashAndCashEquivalentsOfContinuingOperationsBeginningOfYear	303817	usd
CY2022	pavs	Cash And Cash Equivalents Of Continuing Operations Beginning Of Year CashAndCashEquivalentsOfContinuingOperationsBeginningOfYear	355086	usd
CY2024	pavs	Cash And Cash Equivalents Of Discontinued Operations Beginning Of Year CashAndCashEquivalentsOfDiscontinuedOperationsBeginningOfYear	1306125	usd
CY2023	pavs	Cash And Cash Equivalents Of Discontinued Operations Beginning Of Year CashAndCashEquivalentsOfDiscontinuedOperationsBeginningOfYear	19429814	usd
CY2022	pavs	Cash And Cash Equivalents Of Discontinued Operations Beginning Of Year CashAndCashEquivalentsOfDiscontinuedOperationsBeginningOfYear	36203666	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3355487	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19733631	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36558752	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	944242	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3355487	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19733631	usd
CY2024	pavs	Less Cash And Cash Equivalents Of Discontinued Operations End Of Year LessCashAndCashEquivalentsOfDiscontinuedOperationsEndOfYear	0	usd
CY2023	pavs	Less Cash And Cash Equivalents Of Discontinued Operations End Of Year LessCashAndCashEquivalentsOfDiscontinuedOperationsEndOfYear	1306125	usd
CY2022	pavs	Less Cash And Cash Equivalents Of Discontinued Operations End Of Year LessCashAndCashEquivalentsOfDiscontinuedOperationsEndOfYear	19429814	usd
CY2024	pavs	Cash And Cash Equivalents Of Continuing Operations End Of Year CashAndCashEquivalentsOfContinuingOperationsEndOfYear	944242	usd
CY2023	pavs	Cash And Cash Equivalents Of Continuing Operations End Of Year CashAndCashEquivalentsOfContinuingOperationsEndOfYear	2049362	usd
CY2022	pavs	Cash And Cash Equivalents Of Continuing Operations End Of Year CashAndCashEquivalentsOfContinuingOperationsEndOfYear	303817	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	90742	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	29298	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	pavs	Stock Issued For Cash StockIssuedForCash	0	usd
CY2023	pavs	Stock Issued For Cash StockIssuedForCash	3000000	usd
CY2024	pavs	Stock Issued For Cash StockIssuedForCash	0	usd
CY2018Q3	pavs	Equity Method Investment Interest Description EquityMethodInvestmentInterestDescription	Mr. Wang Xuezhu and other shareholders of Fujian Happiness transferred their 100% ownership interests in Fujian Happiness to Happiness Fuzhou, which is 100% owned by Happiness Hong Kong. After the reorganization, Paranovus Cayman owns 100% equity interests of Fujian Happiness. Mr. Wang Xuezhu, who owns 52.37% ownership of Paranovus Cayman, became the ultimate controlling shareholder (“the Controlling Shareholder”) of the Company
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	77223100	shares
CY2024	us-gaap	Profit Loss ProfitLoss	-9927324	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11875246	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61957019	usd
CY2024Q2	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	750000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property, plant and equipment, net and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those estimates.</p>
CY2024	pavs	Sales From Our Product Lines SalesFromOurProductLines	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For the years ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Automobile</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,544,819</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,332,223</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,758,645</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>6,544,819</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>23,332,223</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>20,758,645</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024	us-gaap	Revenues Revenues	6544819	usd
CY2023	us-gaap	Revenues Revenues	23332223	usd
CY2022	us-gaap	Revenues Revenues	20758645	usd
CY2024	pavs	After Tax Profit AfterTaxProfit	0.10	pure
CY2024	pavs	Accumulative Amount Of Reserve AccumulativeAmountOfReserve	0.50	pure
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>Exchange Rate Risks</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and the RMB. As of March 31, 2024 and 2023, cash and cash equivalents of $602,235 (RMB 4,272,854) and $1,825,187 (RMB 12,542,139), respectively, is denominated in RMB and is held in PRC.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>Currency Convertibility Risks</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Substantially all of the Company’s operating activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and signed contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>Concentration of Credit Risks</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Financial instruments that potentially subject the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’ financial condition.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>Interest Rate Risks</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is subject to interest rate risk. Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of adverse changes in the interest rates charged by the banks when these loans are refinanced.</p>
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11360	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	11360	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2024Q1	us-gaap	Supplies Supplies	74362	usd
CY2023Q1	us-gaap	Supplies Supplies	1229829	usd
CY2024Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	273643	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	0	usd
CY2024Q1	pavs	Advance Payment Of Intangible Asset AdvancePaymentOfIntangibleAsset	1500000	usd
CY2023Q1	pavs	Advance Payment Of Intangible Asset AdvancePaymentOfIntangibleAsset	0	usd
CY2024Q1	pavs	Vat Deductibles VatDeductibles	752	usd
CY2023Q1	pavs	Vat Deductibles VatDeductibles	0	usd
CY2024Q1	pavs	Investment Receivables From The Investors InvestmentReceivablesFromTheInvestors	0	usd
CY2023Q1	pavs	Investment Receivables From The Investors InvestmentReceivablesFromTheInvestors	2000000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	47352	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	77673	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1896109	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3307502	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20275	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20934	usd
CY2024Q1	pavs	Less Accumulated Depreciation LessAccumulatedDepreciation	7679	usd
CY2023Q1	pavs	Less Accumulated Depreciation LessAccumulatedDepreciation	7464	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12596	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13470	usd
CY2024	us-gaap	Depreciation Depreciation	1126	usd
CY2023	us-gaap	Depreciation Depreciation	27084	usd
CY2022	us-gaap	Depreciation Depreciation	34610	usd
CY2024	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	5894	usd
CY2023Q1	pavs	Finite Lived Proprietary Technology Gross FiniteLivedProprietaryTechnologyGross	1900000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	1900000	usd
CY2024Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	1900000	usd
CY2024Q1	pavs	Finite Lived Proprietary Technology Gross FiniteLivedProprietaryTechnologyGross	1900000	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	411667	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	31667	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1488333	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1868333	usd
CY2023	us-gaap	Sale Leaseback Transaction Transaction Costs Financing Activities SaleLeasebackTransactionTransactionCostsFinancingActivities	1900000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	380000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31667	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	380000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	380000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	380000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	348333	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1488333	usd
CY2024Q1	us-gaap	Goodwill Gross GoodwillGross	5184036	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	5184036	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1807850	usd
CY2023Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	pavs	Goodwill Net GoodwillNet	3376186	usd
CY2023Q1	pavs	Goodwill Net GoodwillNet	5184036	usd
CY2024	pavs	Scheduleofcarrying Amount Of Goodwilltabletextblock ScheduleofcarryingAmountOfGoodwilltabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong>As of </strong><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong>As of </strong><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Goodwill</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,184,036</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Acquisitions (Note 12)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,184,036</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Impairment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,807,850 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Goodwill, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,376,186</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5,184,036</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024	us-gaap	Goodwill Transfers GoodwillTransfers	5184036	usd
CY2023	us-gaap	Goodwill Transfers GoodwillTransfers	0	usd
CY2024	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5184036	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-1807850	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q1	us-gaap	Goodwill Goodwill	3376186	usd
CY2023Q1	us-gaap	Goodwill Goodwill	5184036	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-1807850	usd
CY2024Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	73953	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	655922	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	7277	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	9900	usd
CY2024Q1	pavs	Loan Payable To The Third Party LoanPayableToTheThirdParty	2289167	usd
CY2023Q1	pavs	Loan Payable To The Third Party LoanPayableToTheThirdParty	0	usd
CY2024Q1	pavs	Deposit Deposit	50000	usd
CY2023Q1	pavs	Deposit Deposit	0	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	139984	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	57488	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2560381	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	723310	usd
CY2023Q4	pavs	Aggregate Loan Amount AggregateLoanAmount	2250000	usd
CY2024	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2020Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y7M6D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted	0	usd
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited	0	usd
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised	0	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2021Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.60
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P3Y7M6D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2022Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.60
CY2022	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P2Y7M6D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8000	shares
CY2023Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	132.00
CY2023	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P1Y7M6D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8000	shares
CY2024Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	132.00
CY2024	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P0Y7M6D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2024	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	effective from January 1, 2008, both domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25% while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. EIT grants preferential tax treatment to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement
CY2024Q1	pavs	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxPercent	0.15	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001	pure
CY2024	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	-0.150	pure
CY2023	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	-0.149	pure
CY2022	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	-0.149	pure
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2996	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	696	usd
CY2024	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	2996	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	696	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	137376	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	88609	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	530886	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	137376	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88609	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	530886	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024Q1	pavs	Value Added Tax Payable ValueAddedTaxPayable	0	usd
CY2023Q1	pavs	Value Added Tax Payable ValueAddedTaxPayable	8694	usd
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	293	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8987	usd
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	1900000	usd
CY2022	pavs	Exchange Gain Amount ExchangeGainAmount	300000	usd
CY2022Q1	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest Prior To Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestPriorToDisposal	1	pure
CY2022Q1	pavs	Over Paid OverPaid	12000000.0	cny
CY2023Q2	pavs	Cash Consideration For Equity Interests CashConsiderationForEquityInterests	11300000	usd
CY2023Q3	pavs	Cash Consideration For Equity Interests CashConsiderationForEquityInterests	700000	usd
CY2024	us-gaap	Risks And Uncertainties In Entitys Business RisksAndUncertaintiesInEntitysBusiness	Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases
CY2022Q3	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.10	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.10	pure

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001929980-24-000320-index-headers.html	Edgar Link	pending
0001929980-24-000320-index.html	Edgar Link	pending
0001929980-24-000320.txt	Edgar Link	pending
0001929980-24-000320-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pavs-20240331.xsd	Edgar Link	pending
pavs_20f.htm	Edgar Link	pending
pavs_20fimg2.jpg	Edgar Link	pending
pavs_ex112.htm	Edgar Link	pending
pavs_ex121.htm	Edgar Link	pending
pavs_ex122.htm	Edgar Link	pending
pavs_ex131.htm	Edgar Link	pending
pavs_ex17.htm	Edgar Link	pending
pavs_ex21.htm	Edgar Link	pending
pavs_ex21img1.jpg	Edgar Link	pending
pavs_ex22.htm	Edgar Link	pending
pavs_ex231.htm	Edgar Link	pending
pavs_ex232.htm	Edgar Link	pending
pavs_ex232img2.jpg	Edgar Link	pending
pavs_ex232img3.jpg	Edgar Link	pending
pavs_ex43.htm	Edgar Link	pending
pavs_ex44.htm	Edgar Link	pending
pavs_ex45.htm	Edgar Link	pending
pavs_ex46.htm	Edgar Link	pending
pavs_ex47.htm	Edgar Link	pending
pavs_ex48.htm	Edgar Link	pending
pavs_ex81.htm	Edgar Link	pending
pavs_ex971.htm	Edgar Link	pending
pavs_ex991.htm	Edgar Link	pending
pavs_ex991img1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
pavs-20240331_cal.xml	Edgar Link	unprocessable
pavs-20240331_def.xml	Edgar Link	unprocessable
pavs-20240331_lab.xml	Edgar Link	unprocessable
pavs-20240331_pre.xml	Edgar Link	unprocessable
pavs_20f_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs

2024 Q3 Form 20-F Financial Statement

#000192998024000320 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAVS Paranovus Entertainment Technology Ltd. Stock $pavs

2024 Q3 Form 20-F Financial Statement

#000192998024000320 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs